Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

New Approaches for the Treatment of Early Stages of Cognitive Impairment in Neurodegenerative Diseases

NCT04118686 is registered in ClinicalTrials.gov with IRCCS National Neurological Institute "C. Mondino" Foundation as lead sponsor.

NCT NCT04118686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04118686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
New Approaches for the Treatment of Early Stages of Cognitive Impairment in Neurodegenerative Diseases
Lead sponsor
IRCCS National Neurological Institute "C. Mondino" Foundation
Phase
Not applicable
Overall status
Unknown status
Start date
March 15, 2017
Completion date
December 15, 2020
Enrollment
19 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment